Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1969 1
1970 1
1973 2
1974 1
1975 1
1978 1
1981 1
1982 2
1983 6
1984 4
1985 5
1986 2
1987 2
1988 5
1989 6
1990 4
1991 2
1992 1
1993 2
1994 2
1996 1
1997 1
1999 1
2003 2
2004 1
2005 2
2006 1
2009 1
2010 1
2021 1
2022 1
2023 5
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.
Monti G, Bradic N, Marzaroli M, Konkayev A, Fominskiy E, Kotani Y, Likhvantsev VV, Momesso E, Nogtev P, Lobreglio R, Redkin I, Toffoletto F, Bruni A, Baiardo Redaelli M, D'Andrea N, Paternoster G, Scandroglio AM, Gallicchio F, Ballestra M, Calabrò MG, Cotoia A, Perone R, Cuffaro R, Montrucchio G, Pota V, Ananiadou S, Lembo R, Musu M, Rauch S, Galbiati C, Pinelli F, Pasin L, Guarracino F, Santarpino G, Agrò FE, Bove T, Corradi F, Forfori F, Longhini F, Cecconi M, Landoni G, Bellomo R, Zangrillo A; MERCY Investigators. Monti G, et al. Among authors: redkin i. JAMA. 2023 Jul 11;330(2):141-151. doi: 10.1001/jama.2023.10598. JAMA. 2023. PMID: 37326473 Free PMC article.
A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis.
Monti G, Carta S, Kotani Y, Bruni A, Konkayeva M, Guarracino F, Yakovlev A, Cucciolini G, Shemetova M, Scapol S, Momesso E, Garofalo E, Brizzi G, Baldassarri R, Ajello S, Isirdi A, Meroi F, Baiardo Redaelli M, Boffa N, Votta CD, Borghi G, Montrucchio G, Rauch S, D'Amico F, Pace MC, Paternoster G, Vitale F, Giardina G, Labanca R, Lembo R, Marmiere M, Marzaroli M, Nakhnoukh C, Plumari V, Scandroglio AM, Scquizzato T, Sordoni S, Valsecchi D, Agrò FE, Finco G, Bove T, Corradi F, Likhvantsev V, Longhini F, Konkayev A, Landoni G, Bellomo R, Zangrillo A; PPI-SEPSIS Study Group. Monti G, et al. Crit Care Med. 2025 Aug 1;53(8):e1554-e1566. doi: 10.1097/CCM.0000000000006720. Epub 2025 May 29. Crit Care Med. 2025. PMID: 40439536 Clinical Trial.
TREC/KREC Levels in Young COVID-19 Patients.
Khadzhieva MB, Kalinina EV, Larin SS, Sviridova DA, Gracheva AS, Chursinova JV, Stepanov VA, Redkin IV, Avdeikina LS, Rumyantsev AG, Kuzovlev AN, Salnikova LE. Khadzhieva MB, et al. Among authors: redkin iv. Diagnostics (Basel). 2021 Aug 16;11(8):1486. doi: 10.3390/diagnostics11081486. Diagnostics (Basel). 2021. PMID: 34441420 Free PMC article.
[Anti-allergic agents].
Red'kin IuV. Red'kin IuV. Eksp Klin Farmakol. 1996 Mar-Apr;59(2):62-8. Eksp Klin Farmakol. 1996. PMID: 8974571 Russian. No abstract available.
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial.
Monti G, Konkayev A, Carta S, Bradic N, Bruni A, Kotani Y, Guarracino F, Redkin I, Biondi-Zoccai G, Benedetto U, D'Ascenzo F, Garofalo E, Baiardo Redaelli M, Brizzi G, Forfori F, Borghi G, Scapol S, Momesso E, Cuffaro R, Boffa N, Rauch S, D'Amico F, Montrucchio G, Pace MC, Galbiati C, Bosso S, Savelli F, Giardina G, Silvetti S, Tripodi VF, Labanca R, Lembo R, Marmiere M, Marzaroli M, Nakhnoukh C, Valsecchi D, Finco G, Agrò FE, Bove T, Corradi F, Longhini F, Landoni G, Bellomo R, Zangrillo A; Collaborators. Monti G, et al. Among authors: redkin i. Contemp Clin Trials. 2023 Oct;133:107319. doi: 10.1016/j.cct.2023.107319. Epub 2023 Aug 23. Contemp Clin Trials. 2023. PMID: 37625587 Free article.
COVID-19 severity: does the genetic landscape of rare variants matter?
Khadzhieva MB, Gracheva AS, Belopolskaya OB, Kolobkov DS, Kashatnikova DA, Redkin IV, Kuzovlev AN, Grechko AV, Salnikova LE. Khadzhieva MB, et al. Among authors: redkin iv. Front Genet. 2023 Jun 29;14:1152768. doi: 10.3389/fgene.2023.1152768. eCollection 2023. Front Genet. 2023. PMID: 37456666 Free PMC article.
75 results